Related Experiment Video

Updated: Jun 14, 2026

High-Density Lipoprotein-Specific Phospholipid Efflux Assay
07:08

High-Density Lipoprotein-Specific Phospholipid Efflux Assay

Published on: September 30, 2025

Targeting residual risk: the rationale for the use of non-HDL cholesterol

Venkata M Alla1, Manu Kaushik, Aryan Mooss

  • 1Division of Cardiology, Creighton University Medical Center, Omaha, NE, USA.

Southern Medical Journal
|April 9, 2010
PubMed

Insights

Despite aggressive LDL cholesterol lowering, patients face residual cardiovascular risk. Non-HDL cholesterol (non-HDLc) offers a valuable metric for assessing and managing this risk, guiding therapeutic strategies in primary care.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Clinical Lipidology

Background:

  • Low-density lipoprotein cholesterol (LDLc) reduction significantly lowers cardiovascular event rates.
  • A substantial residual risk for recurrent events persists in patients despite aggressive LDLc lowering.
  • Alternative lipid parameters are needed to address this residual risk.

Purpose of the Study:

  • To discuss the rationale and evidence supporting the use of non-high density lipoprotein cholesterol (non-HDLc) for residual risk assessment.
  • To explore therapeutic options for managing residual cardiovascular risk.
  • To provide a primary care-focused approach to residual risk reduction.

Main Methods:

  • Review of epidemiological and clinical data on LDLc and cardiovascular disease.
  • Analysis of evidence supporting non-HDLc as a risk assessment tool.
  • Discussion of therapeutic strategies for lipid management.

Main Results:

  • LDLc reduction is effective but does not eliminate cardiovascular risk.
  • Non-HDLc is a valuable metric for assessing residual risk.
  • Multiple therapeutic options exist for managing residual risk.

Conclusions:

  • Non-HDLc measurement is crucial for comprehensive cardiovascular risk assessment.
  • Targeting non-HDLc can help mitigate residual cardiovascular risk.
  • A practical, primary care-based approach is essential for effective residual risk management.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...